Credits: King's College Hospital NHS Foundation Trust
Eight-month-old twins from Hayward Heath, West Sussex, recently met the surgeon who saved their lives even before they were born. The BBC reports how their mother, Katerina Ahouansou, at six months pregnant, during a routine scan, uncovered a serious issue with their development and blood supply.
Doctors diagnosed the twins with twin-to-twin transfusion syndrome or TTTS. It is a condition where one twin received more blood and nourishment than the other due to uneven blood vessel distribution in the placenta. In case there is no medical intervention, it could be fatal for both the twins.
This is when Ahouansou was referred to Professor Kypros Nicolaides at King’s College Hospital in London. Professor Nicolaides is a pioneer in fetal medicine and he specializes in a laser procedure that redistributes blood supply between twins in cases of TTTS.
When Ahouansou was scanned, Nicolaides observed that one of the twins were significantly smaller than the other. "There was a very high chance that if we did not intervene, both twins could die," he recalled.
The life-saving laser surgery was performed and within a week the doctors saw an improvement with the twin who was smaller in size. When the twins were born, they weighed 1.5kg and 1.7kg. To recognize the efforts by the surgeon, Ahouansou named them Kai Kypros and Asher Nicolas after Professor Kypros Nicolaides.
Ahouansou also expressed deep gratitude for the professor's expertise and called him "proof that miracles can be performed by people who are devotees to their profession."
Professor Kypros Nicolaides has been at King’s College Hospital since 1980 and is widely regarded as a leader in fetal medicine. His groundbreaking research and development of screening and surgical techniques have saved countless lives.
Through his dedication, Professor Nicolaides has given many families hope, demonstrating how medical advancements continue to improve survival rates for complex fetal conditions like TTTS.
As per the John Hopkins Medicine, TTTS is a rare pregnancy condition that affects identical twins or other multiples. It happens in pregnancies where twins share one placenta and a network of blood vessels that supply oxygen and nutrients essential for development in the womb. These pregnancies are known as monochorionic.
Sometimes, the blood vessels in the placenta are unevenly distributed, causing an imbalance in blood flow between the twins. The donor twin loses more blood than it receives, leading to malnutrition and potential organ failure. Meanwhile, the recipient twin gets an excess of blood, putting strain on the heart and increasing the risk of cardiac complications.
The donor twin loses blood volume (hypovolemia), reducing kidney function and urine production. This leads to low amniotic fluid levels (oligohydramnios) or, in severe cases, a complete absence (anhydramnios). Without proper blood circulation, the donor twin faces cardiovascular issues, increasing the risk of death.
The recipient twin experiences excess blood volume (hypervolemia), causing increased urination and excessive amniotic fluid (polyhydramnios). The overworked heart struggles to handle the surplus blood, leading to cardiovascular dysfunction, heart failure, and, in extreme cases, death.
Credits: Canva
The World Health Organization (WHO) has released its first global guidelines dedicated specifically to the management of diabetes during pregnancy, a major milestone for maternal and newborn health. Diabetes affects one in six pregnancies worldwide, impacting nearly 21 million women every year, and the newly released recommendations aim to transform how this growing health challenge is recognized, treated, and prevented across all health systems.
Diabetes during pregnancy, whether pre-existing or gestational, can be dangerous if not properly managed. Poor blood sugar control significantly raises the risk of pre-eclampsia, stillbirth, obstructed labor, birth injuries, and other complications. The long-term consequences are equally serious: both mothers and babies face a higher lifetime risk of type 2 diabetes, heart disease, and other cardiometabolic disorders.
The impact is especially severe in low- and middle-income countries, where women often lack access to early screening, essential medicines, glucose testing supplies, and specialized care. These guidelines are intended to close those gaps and ensure that women everywhere receive timely, high-quality support.
While WHO has previously offered guidance on general diabetes management and separate recommendations for pregnancy, this is the first time a specific, unified standard of care has been created for diabetes during pregnancy.
“These guidelines are grounded in the realities of women's lives and health needs, and provide clear, evidence-based strategies to deliver high-quality care for every woman, everywhere,” said Dr. Tedros Adhanom Ghebreyesus, WHO Director-General.
The guidelines outline 27 key recommendations, covering the full spectrum of prevention, screening, and treatment.
The WHO stresses the need for personalized, culturally appropriate guidance on:
By tailoring these recommendations, healthcare providers can better support women in managing day-to-day glucose levels throughout pregnancy.
Regular and accurate monitoring is central to safe pregnancy care. The guidelines recommend:
Treatment must differ for type 1 diabetes, type 2 diabetes, and gestational diabetes. When lifestyle changes alone are not enough, the guidelines outline clear medication pathways for insulin and other pharmacologic options.
Women with pre-existing diabetes should receive coordinated care involving obstetricians, endocrinologists, nutritionists, and diabetes educators to reduce risks throughout pregnancy and childbirth.
Launched on World Diabetes Day 2025, the guidelines align with this year’s theme, “Diabetes Across Life Stages,” which highlights the need for lifelong diabetes awareness, prevention, and care. The campaign emphasizes that every person, child, adolescent, adult, or older adult, deserves access to integrated services that preserve dignity, health, and long-term well-being.
Diabetes remains one of the world’s fastest-growing health threats, currently affecting over 800 million people. It is a leading cause of heart disease, kidney failure, blindness, and limb amputation. Its rise has been steepest in resource-limited regions, where access to screening and essential medicines is often inadequate.
By centering diabetes management across all life stages, WHO’s new guidelines highlight the urgent need for health systems to expand antenatal care, improve access to diagnostic tools, and ensure equitable availability of essential medicines. Strengthening diabetes care during pregnancy is not only lifesaving—it protects future generations and helps build healthier societies worldwide.
Credits: Canva
Many breakthroughs in medicine, and now there is also a baby conceived without a womb, but from an artificial intelligence based fertilization (IVF) system.
This happened in Guadalajara, Mexico, where a 40-year-old woman gave birth to the world's first baby conceived through an AI-assisted IVF process. The groundbreaking event was made possible by a sperm-injecting robot, which was remotely operated by fertility specialists based in New York.
The innovation was made possible by the process called Intracytoplasmic Sperm Injection (ICSI), a method where a single sperm is injected directly into an egg under a microscope.
Traditionally, this delicate task requires the steady hands and precision of highly skilled embryologists. However, even the most experienced professionals face limitations in accuracy and consistency.
That’s where AI comes in. The AI-powered robot, developed by the New York-based biotech firm Conceivable Life Sciences, follows 23 precise programmed steps: from sperm selection to injection, with remarkable accuracy. In this experiment, five eggs were fertilized, four developed into embryos, and on the second transfer attempt, the world’s first AI-assisted baby was born.
IVF has long been a mix of science and art, heavily dependent on human judgment and precision. Success rates vary widely depending on expertise and timing. But with automation, the process can become standardized and more predictable, reducing the room for error.
Experts suggest that AI can not only perform fertilization but also learn from each cycle. Its algorithms can analyze which sperm are healthiest, which embryos are most viable, and which steps produce the best outcomes. In essence, it acts like a tireless embryologist, one that doesn’t fatigue or make emotional decisions.
AI-assisted technology could also help make fertility treatments more affordable and accessible. In India, IVF costs range between ₹1.5 lakh to ₹3 lakh per cycle, and many couples require multiple attempts. By automating intricate steps, clinics could eventually lower costs and reduce waiting times.
According to reproductive endocrinology experts, automation will allow fertility centers to scale up care, reaching people who currently lack access to advanced reproductive services. Conceivable Life Sciences co-founder Alejandro Chavez-Badiola envisions a future where every IVF lab is equipped with a robotic assistant working alongside human specialists, ensuring precision, consistency, and faster results.
Infertility affects over 48 million couples worldwide, often leading to deep emotional and financial distress. Each failed IVF attempt can feel devastating. The AI-IVF breakthrough offers a new ray of hope, potentially improving success rates by minimizing embryo damage and accurately identifying the most viable ones. For many couples, this could mean fewer procedures and quicker success.
However, the rise of AI in reproduction raises important ethical and accountability questions. Should AI decide which embryo is chosen? Who is responsible if something goes wrong? Would it be the doctor, the programmer, or the machine?
Medical experts agree that while AI can enhance accuracy, human oversight remains essential. The emotional and ethical aspects of creating life cannot be reduced to algorithms. As one expert noted, “AI may handle the how, but humans must still decide the why.”
Credits: Instagram
Catherine Paiz, is pregnant at 35 and is expecting her fourth baby. This is her first with husband Igon Ten. Paiz shared the news on her Instagram page and wrote that she was "so shocked" to learn the news about her pregnancy.
On her Instagram post, she wrote: "I'm pregnant!!!!! Still so shocked ahhhhh". She also included videos of her taking the pregnancy test, where she could be heard saying, "Last night I peed about five times and I'm curious. I'm confused. I'm exactly one month from the day I got married today. It is the 27th of October."
Also Read: What Is Hormone Replacement Therapy for Menopause? What Will Change Under Recent FDA Guidelines?
Paiz pregnancy at 35 has yet again sparked spotlight on late motherhood trends. In fact, data also shows the same trend.

The average age of mothers in the US have continued to rise, a new report released on June 13 by the National Vital Statistic System (NVSS), provides the shift in age trends between 2016 and 2023. The study, conducted by Andrea D. Brown, Ph.D., M.P.H., and her colleagues at the National Center for Health Statistics.
The researchers found a clear increase in the mean age of mothers at the time of their first birth. In 2016, the average age of a first-time mother was 26.6 years. By 2023, this had risen to 27.5 years — nearly a full year’s difference in just seven years.
Also Read: Intermittent Fasting and Brain Health: Is There a Risk of Cognitive Decline?
But the trend isn’t limited to first-time mothers. In Paiz's case, she is having her fourth child at 35.
The National Institute of Health (NIH), US (2022), 20% of women in the US are now having their first child after the age of 35. While it is the new trend, the NIH doctor Dr Alan Decherney, a fertility expert explains that "As women age, they are still fertile, but their odds of pregnancy are decreased because they are not making as many good eggs that will fertile and divide normally and turn out to be an embryo."
After age 30, a woman's fertility decreases ever year, notes the NIH July 2022 issue. It notes: "The number and quality of her eggs goes down until she reaches menopause."
However, experts do point out that getting pregnant in your 30s need not be a stressful affair at all times. As it is at this age when you experience more stability, and also someone you know who have a personal experience in handling one. Most important, you are more mature at this age, which you may not be in your 20s.
Also Read: Davina McCall Reveals Breast Cancer Surgery A Year After Her Brain Tumor Surgery
Quit Habits: If you are a smoker, or consume alcohol, this is a good time to leave it.
Reduce Stress: While pregnancy for some can bring stress, try to find activities that help you release it.
Healthy Weight: Ensure that your weight is right, reduce your waist to bring it to a healthy range for a healthy pregnancy.
Food Habits: Stop eating junk and start eating more whole grains.
Exercise: A sedentary lifestyle can impact negatively on the child. You do not have to do HIIT, however, regular easy workouts can make both the pregnancy and delivery easy.
Dr Michelle Y Owens, professor of obstetrics and gynecology and a practicing maternal-fetal medicine specialist at the University of Mississippi Medical Center in Jackson, writes for the American College of Obstetricians and Gynecologists (ACOG) that "the longer your eggs have been around, the more likely they are to produce a pregnancy with a chromosome problem that can lead to a condition like Down syndrome. The risk goes up significantly after 35." However, she says, there is a good news. Now, we have tools to detect and respond to pregnancy complications early.
© 2024 Bennett, Coleman & Company Limited